CNR2 and multiple sclerosis: In the same way that fully standardized chemotypes of the Cannabis plant have been developed as nabiximols (Sativex®) for clinical use against spasticity in multiple sclerosis, it would be possible to develop chemotypes rich in CBD, THCV, and/or β-caryophyllene (a terpene with CB2 agonist action found also in other plants63) for the prevention or treatment of NAFLD.